Daiwa Securities Group Inc. Organon & Co. Transaction History

Daiwa Securities Group Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$16.59 - $23.77 $13,736 - $19,681	828 Added 15.91%	6,032 $105,000
Q2 2023 Jul 31, 2023	BUY	$19.27 - $24.63 $10,347 - $13,226	537 Added 11.51%	5,204 $108,000
Q1 2023 May 02, 2023	BUY	$21.42 - $32.08 $10,731 - $16,072	501 Added 12.03%	4,667 $110,000
Q4 2022 Feb 06, 2023	BUY	$23.31 - $28.61 $11,678 - $14,333	501 Added 13.67%	4,166 $116,000
Q3 2022 Nov 02, 2022	BUY	$23.4 - $34.25 $9,219 - $13,494	394 Added 12.05%	3,665 $86,000
Q2 2022 Aug 09, 2022	BUY	$31.66 - $38.9 $14,278 - $17,543	451 Added 15.99%	3,271 $110,000
Q1 2022 Apr 29, 2022	BUY	$30.45 - $39.36 $7,764 - $10,036	255 Added 9.94%	2,820 $99,000
Q4 2021 Feb 03, 2022	BUY	$28.67 - $37.13 $1,204 - $1,559	42 Added 1.66%	2,565 $78,000
Q3 2021 Nov 05, 2021	BUY	$28.63 - $35.64 $7,329 - $9,123	256 Added 11.29%	2,523 $83,000
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $64,496 - $86,146	2,267 New	2,267 $69,000

786

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.04B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.